The FeNO analyzer is an innovative Point-of-Care medical device designed to monitor the fractionated nitric oxide level in exhaled air—an essential indicator of airway inflammation. Whether for asthma or other pulmonary conditions, this device offers a non-invasive and fast method, equipped with integrated software, easy to use for diagnostic and monitoring purposes.
Fractionated nitric oxide (FeNO) is a relevant biomarker for pulmonary inflammation. Elevated values can indicate airway inflammation, often associated with conditions such as asthma. Measuring FeNO helps doctors and patients assess treatment response and adjust therapy effectively, contributing to better symptom control and reduced exacerbation risks.
The spirometer is an essential medical device for evaluating respiratory function, frequently used in diagnosing and monitoring conditions such as asthma, chronic obstructive pulmonary disease (COPD), or pulmonary fibrosis. It accurately measures inhaled and exhaled air volumes and flow rates, providing objective data about a patient’s lung capacity.
The test is non-invasive, fast, and easy to perform, suitable for use in hospitals, outpatient clinics, or family medicine practices. Spirometry results help medical staff identify airway obstructions or restrictions, evaluate treatment effectiveness, and develop personalized therapeutic plans. The spirometer thus contributes to early diagnosis and effective management of respiratory diseases.
*The images shown are for illustration purposes only and may not be an exact representation of the product.
Approved by the Romanian National Agency for Medicines and Medical Devices
